Clinical Study

Observation For Severe Hemolytic Anemia Of The Fetus

Posted Date: Jun 14, 2019

  • Investigator: Kara Markham
  • Specialties:
  • Type of Study: Observational/Survey

Because you had a prior child with severe anemia, your baby has an increased risk of being affected by Hemolytic Disease of the Fetus and Newborn (HDFN) in this pregnancy. Currently, the treatment options for HFDN are quite limited, and a pharmaceutical company called Momenta is trying to develop a new medicine which it hopes will treat HDFN better than at present. However, to be able to assess how well their drug works, Momenta also needs to collect more information about the way HDFN is normally treated, and how successful that is.


Women Must Be At Least 8 Weeks Pregnant Currently With A History Of A Prior Pregnancy Complicated By Severe Anemia Prior To 24 Weeks Of Gestation. Patients Must Be At Least 18 Years Old To Enroll, And Must Confirm That Your Baby Has A Positive Antigen To The Red Blood Cell Antibody.


Hemolytic Anemia, Fetal Anemia, Antibodies

For More Information:

Kara Markham

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.